Literature DB >> 29464684

Neuregulin directed molecular mechanisms of visual cortical plasticity.

Steven F Grieco1,2,3,4, Todd C Holmes1,2,3,4, Xiangmin Xu1,2,3,4.   

Abstract

Experience-dependent critical period (CP) plasticity has been extensively studied in the visual cortex. Monocular deprivation during the CP affects ocular dominance, limits visual performance, and contributes to the pathological etiology of amblyopia. Neuregulin-1 (NRG1) signaling through its tyrosine kinase receptor ErbB4 is essential for the normal development of the nervous system and has been linked to neuropsychiatric disorders such as schizophrenia. We discovered recently that NRG1/ErbB4 signaling in PV neurons is critical for the initiation of CP visual cortical plasticity by controlling excitatory synaptic inputs onto PV neurons and thus PV-cell mediated cortical inhibition that occurs following visual deprivation. Building on this discovery, we review the existing literature of neuregulin signaling in developing and adult cortex and address the implication of NRG/ErbB4 signaling in visual cortical plasticity at the cellular and circuit levels. NRG-directed research may lead to therapeutic approaches to reactivate plasticity in the adult cortex.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  ErbB4; PV neurons; neural plasticity; neuregulin-1; visual cortex

Mesh:

Substances:

Year:  2018        PMID: 29464684      PMCID: PMC6103898          DOI: 10.1002/cne.24414

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  114 in total

1.  Structural and functional recovery from early monocular deprivation in adult rats.

Authors:  Tommaso Pizzorusso; Paolo Medini; Silvia Landi; Sara Baldini; Nicoletta Berardi; Lamberto Maffei
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-18       Impact factor: 11.205

2.  Comparison of different iodine concentration contrast media in perfusion computed tomography of the brain: is high iodine concentration useful?

Authors:  Stephan P Kloska; Tobias Fischer; Darius G Nabavi; Johannes Wessling; Ralf Dittrich; Roman Fischbach; Peter Seidensticker; E Bernd Ringelstein; Walter Heindel
Journal:  Invest Radiol       Date:  2007-08       Impact factor: 6.016

3.  Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors.

Authors:  Graham M Pitcher; Lorraine V Kalia; David Ng; Nathalie M Goodfellow; Kathleen T Yee; Evelyn K Lambe; Michael W Salter
Journal:  Nat Med       Date:  2011-03-27       Impact factor: 53.440

4.  Differential expression of ErbB3 and ErbB4 neuregulin receptors in dopamine neurons and forebrain areas of the adult rat.

Authors:  H Steiner; M Blum; S T Kitai; P Fedi
Journal:  Exp Neurol       Date:  1999-10       Impact factor: 5.330

Review 5.  Neuregulin signaling, cortical circuitry development and schizophrenia.

Authors:  Beatriz Rico; Oscar Marín
Journal:  Curr Opin Genet Dev       Date:  2011-02-04       Impact factor: 5.578

6.  A comparison of koniocellular, magnocellular and parvocellular receptive field properties in the lateral geniculate nucleus of the owl monkey (Aotus trivirgatus).

Authors:  X Xu; J M Ichida; J D Allison; J D Boyd; A B Bonds; V A Casagrande
Journal:  J Physiol       Date:  2001-02-15       Impact factor: 5.182

7.  Neuregulin blocks synaptic strengthening after epileptiform activity in the rat hippocampus.

Authors:  Sloka S Iyengar; David D Mott
Journal:  Brain Res       Date:  2008-02-29       Impact factor: 3.252

8.  Principles of connectivity among morphologically defined cell types in adult neocortex.

Authors:  Xiaolong Jiang; Shan Shen; Cathryn R Cadwell; Philipp Berens; Fabian Sinz; Alexander S Ecker; Saumil Patel; Andreas S Tolias
Journal:  Science       Date:  2015-11-27       Impact factor: 47.728

Review 9.  Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases.

Authors:  Lin Mei; Klaus-Armin Nave
Journal:  Neuron       Date:  2014-07-02       Impact factor: 17.173

Review 10.  Neuregulin 1 in neural development, synaptic plasticity and schizophrenia.

Authors:  Lin Mei; Wen-Cheng Xiong
Journal:  Nat Rev Neurosci       Date:  2008-05-14       Impact factor: 34.870

View more
  6 in total

1.  Subanesthetic Ketamine Reactivates Adult Cortical Plasticity to Restore Vision from Amblyopia.

Authors:  Steven F Grieco; Xin Qiao; Xiaoting Zheng; Yongjun Liu; Lujia Chen; Hai Zhang; Zhaoxia Yu; Jeffrey P Gavornik; Cary Lai; Sunil P Gandhi; Todd C Holmes; Xiangmin Xu
Journal:  Curr Biol       Date:  2020-08-20       Impact factor: 10.834

2.  Neuregulin and ErbB expression is regulated by development and sensory experience in mouse visual cortex.

Authors:  Steven F Grieco; Gina Wang; Ananya Mahapatra; Cary Lai; Todd C Holmes; Xiangmin Xu
Journal:  J Comp Neurol       Date:  2019-09-18       Impact factor: 3.215

3.  ErbB3 is a critical regulator of cytoskeletal dynamics in brain microvascular endothelial cells: Implications for vascular remodeling and blood brain barrier modulation.

Authors:  Limin Wu; Mohammad R Islam; Janice Lee; Hajime Takase; Shuzhen Guo; Allison M Andrews; Tetyana P Buzhdygan; Justin Mathew; Wenlu Li; Ken Arai; Eng H Lo; Servio H Ramirez; Josephine Lok
Journal:  J Cereb Blood Flow Metab       Date:  2021-02-14       Impact factor: 6.200

4.  The effects of neuregulin-1β on intrafusal muscle fiber formation in neuromuscular coculture of dorsal root ganglion explants and skeletal muscle cells.

Authors:  Yuan Qiao; Menglin Cong; Jianmin Li; Hao Li; Zhenzhong Li
Journal:  Skelet Muscle       Date:  2018-09-15       Impact factor: 4.912

5.  ErbB4 Null Mice Display Altered Mesocorticolimbic and Nigrostriatal Dopamine Levels as well as Deficits in Cognitive and Motivational Behaviors.

Authors:  Miguel Skirzewski; Marie E Cronin; Ricardo Murphy; Wambura Fobbs; Alexxai V Kravitz; Andres Buonanno
Journal:  eNeuro       Date:  2020-05-21

6.  Neuregulin signaling mediates the acute and sustained antidepressant effects of subanesthetic ketamine.

Authors:  Steven F Grieco; Xin Qiao; Kevin G Johnston; Lujia Chen; Renetta R Nelson; Cary Lai; Todd C Holmes; Xiangmin Xu
Journal:  Transl Psychiatry       Date:  2021-02-24       Impact factor: 6.222

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.